Immunic (IMUX) director Elena Ridloff files Form 3 showing no share ownership

Rhea-AI Filing Summary

IMMUNIC, INC. reported that director Elena Ridloff filed an initial statement of beneficial ownership. The filing states that no securities are beneficially owned by the reporting person as of this report, and it discloses no transactions or holdings in the company’s securities.

Key Figures

Beneficially owned securities: 0

1 metrics

Beneficially owned securities 0 Form 3 remarks state no securities are beneficially owned by the reporting person

Key Terms

beneficially owned, initial statement of beneficial ownership

2 terms

beneficially owned financial

"Remarks state: No securities are beneficially owned."

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

initial statement of beneficial ownership regulatory

"Director filed an initial statement of beneficial ownership."

An initial statement of beneficial ownership is the first regulatory filing an insider or large investor submits to disclose the amount of a company's stock they control or benefit from. It matters to investors because it reveals who has significant influence over a company—like showing who’s holding the cards—and helps track potential conflicts of interest, insider motives, and future buying or selling that can move the stock price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 08/10/2026 - 06:59 PM Accepted by SEC EDGAR 08/10/2026 - 06:59 PM Learn about SEC filing dates

FAQ

What does Immunic (IMUX) report in Elena Ridloff’s Form 3?

Immunic (IMUX) reports that director Elena Ridloff filed a Form 3 initial ownership statement. The filing notes that she does not beneficially own any Immunic securities as of the reporting date.

Does Elena Ridloff own any IMUX shares according to this Form 3?

According to the Form 3, no securities are beneficially owned by director Elena Ridloff. The filing lists no common stock or derivative securities positions for her at this time.

Are there any transactions reported for Elena Ridloff in IMUX stock?

No. The Form 3 for Immunic (IMUX) shows no reported transactions by director Elena Ridloff. The transaction section is empty and reflects no purchases, sales, or derivative exercises.

What role does Elena Ridloff have at Immunic (IMUX) in this Form 3?

The Form 3 identifies Elena Ridloff as a director of Immunic (IMUX). She is not listed as an officer or 10% owner, and she reports no beneficial ownership of company securities.

Why is a Form 3 filed for Immunic (IMUX) if no shares are owned?

A Form 3 is required when a person becomes an officer, director, or 10% owner. For Immunic (IMUX), director Elena Ridloff filed to report her status, and the form notes she currently owns no securities beneficially.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ridloff Elena

(Last) (First) (Middle)

1200 AVENUE OF THE AMERICAS, SUITE 200

(Street)

NEW YORK NEW YORK 10036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/06/2026

3. Issuer Name and Ticker or Trading Symbol
IMMUNIC, INC. [ IMUX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No securities are beneficially owned.

No securities are beneficially owned.

	/s/ Elena Ridloff	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)